Exploring the Role of p53 in Radiosensitivity: A Key Player in Cancer Therapy DOI Creative Commons
Tusher- Al-Arafat,

Aihong Mao,

Takanori Katsube

и другие.

Radiation, Год журнала: 2024, Номер 4(4), С. 309 - 324

Опубликована: Окт. 24, 2024

Radiotherapy remains a cornerstone in cancer treatment, leveraging ionizing radiation to eradicate malignant cells. Its efficacy, however, is frequently challenged by the heterogeneous sensitivity of tumors and surrounding tissues radiation. Therefore, understanding molecular mechanisms underlying radiosensitivity crucial for improving treatment outcomes. Among myriad players involved, tumor suppressor protein p53 stands out as central regulator with significant implications radiosensitivity. Known “guardian genome”, plays pivotal role maintaining genomic stability orchestrating cellular responses such cell cycle arrest, DNA repair, apoptosis, senescence response various stress signals, including radiation-induced damage. Activation triggers transcription target genes involved repair pathways, p21, MDM2, GADD45, facilitating damage or elimination irreparably damaged This, turn, influences overall tissues. Mutations TP53 gene, which encodes p53, are among most frequent genetic alterations human cancers. Loss dysfunction can compromise radiation, leading increased resistance therapy poorer clinical Conversely, intact function associated enhanced due its ability promote arrest apoptosis In conclusion, elucidating essential advancing our cells developing more effective therapeutic approaches treatment. This review provides comprehensive overview multifaceted modulating emphasizing influence on

Язык: Английский

Multi-modal data integration of dosiomics, radiomics, deep features, and clinical data for radiation-induced lung damage prediction in breast cancer patients DOI
Li Yan, Jun Jiang,

X. Li

и другие.

Journal of Radiation Research and Applied Sciences, Год журнала: 2025, Номер 18(2), С. 101389 - 101389

Опубликована: Март 3, 2025

Язык: Английский

Процитировано

0

A Feasibility Study of Liver Conformal Therapy Based on Minimally Invasive Steam Interventional Thermal Ablation: Design, Simulation, and Experimental Research DOI

Liangxinyu Su,

Qian Lu, Yamin Yang

и другие.

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

Ionizing Radiation May Induce Tumors Partly Through the Alteration or Regulation of Mismatch Repair Genes DOI Open Access
Mingzhu Sun, Kevin Monahan, Jayne Moquet

и другие.

Cancers, Год журнала: 2025, Номер 17(4), С. 564 - 564

Опубликована: Фев. 7, 2025

Ionizing radiation is mutagenic and carcinogenic, it reported to induce primary secondary tumors with intestinal being one of the most commonly observed. However, pathological molecular mechanism(s) underlying radiation-associated tumorigenesis remain unclear. A link between somatic partly through genetic, epigenetic alteration and/or regulation mismatch repair (MMR) genes has been hypothesized for first time within this review. Clinical observations experimental findings provide significant support association including MMR mutations as well altered RNA protein expressions that occurred post-exposure, although existing evidence in published literature sparse niche area. Some speculative mechanisms are suggested review inform future research. Further studies needed understand roles system response test possible connection which could potentially useful urgently information clinical guidance.

Язык: Английский

Процитировано

0

A feasibility study of liver conformal therapy based on minimally invasive steam interventional thermal ablation: Design, simulation, and experimental research DOI

Liangxinyu Su,

Qian Lu, Yamin Yang

и другие.

International Communications in Heat and Mass Transfer, Год журнала: 2025, Номер 164, С. 108924 - 108924

Опубликована: Апрель 6, 2025

Язык: Английский

Процитировано

0

Exploring the Role of p53 in Radiosensitivity: A Key Player in Cancer Therapy DOI Creative Commons
Tusher- Al-Arafat,

Aihong Mao,

Takanori Katsube

и другие.

Radiation, Год журнала: 2024, Номер 4(4), С. 309 - 324

Опубликована: Окт. 24, 2024

Radiotherapy remains a cornerstone in cancer treatment, leveraging ionizing radiation to eradicate malignant cells. Its efficacy, however, is frequently challenged by the heterogeneous sensitivity of tumors and surrounding tissues radiation. Therefore, understanding molecular mechanisms underlying radiosensitivity crucial for improving treatment outcomes. Among myriad players involved, tumor suppressor protein p53 stands out as central regulator with significant implications radiosensitivity. Known “guardian genome”, plays pivotal role maintaining genomic stability orchestrating cellular responses such cell cycle arrest, DNA repair, apoptosis, senescence response various stress signals, including radiation-induced damage. Activation triggers transcription target genes involved repair pathways, p21, MDM2, GADD45, facilitating damage or elimination irreparably damaged This, turn, influences overall tissues. Mutations TP53 gene, which encodes p53, are among most frequent genetic alterations human cancers. Loss dysfunction can compromise radiation, leading increased resistance therapy poorer clinical Conversely, intact function associated enhanced due its ability promote arrest apoptosis In conclusion, elucidating essential advancing our cells developing more effective therapeutic approaches treatment. This review provides comprehensive overview multifaceted modulating emphasizing influence on

Язык: Английский

Процитировано

0